A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug ...

Behind the buzz around Mounjaro lies a larger conversation about who really needs it.

CagriSema’s blood sugar and weight reductions exceeded the company’s blockbuster Wegovy, yet the drug might still struggle to ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

The 6 best GLP-1 foods to curb hunger naturally In general, "high-fiber and protein-rich diets stimulate GLP-1 secretion, reducing hunger and improving metabolic health," notes Hamrick. But there are ...

Now, it’s worth noting Stock Advisor’s total average return is 913 % — a market-crushing outperformance compared to 196% for ...

The investigational GLP-1 receptor agonist MET-097i, which may be able to be dosed just once a month, yielded weight loss of up to 14.1% by week 28 with class-leading tolerability in a phase IIb trial ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." MORE AMERICANS THAN EVER are taking weight-loss drugs or considering them. Now, they have a new option.

Gina Roberts folds up blankets on her bed in the sober home where she’s been living in Providence, R.I. on Feb. 2. She has ...